📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Comparison of mouse models reveals a molecular distinction between psychotic illness in PWS and schizophrenia (2021)

First Author: Zahova S

Attributed to: De-risking PWS drug development through preclinical screening funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.01.26.428232

Publication URI: http://dx.doi.org/10.1101/2021.01.26.428232

Type: Preprint